Increasing prevalence of skin diseases is the primary factor expected to drive the leprosy treatment market over the forecast period. The prevalence of skin diseases, [read full press release…]
Albany, US, 2019-Jul-16 — /EPR Network/ —The relentless innovation in the bio-pharmaceutical industry has accentuated development of a novel category of biopharmaceuticals— biosuperiors or biobetters. [read full press release…]
ALBANY, US, 2019-Apr-05 — /EPR Network/ — On the back of exponential rise in R&D initiatives towards cancer therapeutics, coupled with large scale developments in [read full press release…]
